Prediction of epitopes in hemagglutinin and neuraminidase proteins of influenza A virus H5N1 strain: A clue for diagnostic and vaccine development

OMICS A Journal of Integrative Biology

Volumn 12, Issue 1, 2008, Pages 61-69

  Somvanshi, Pallavi ^a   Singh, Vijay ^b   Seth, P K ^c  

^a Biotech Park   (India)

^b NATIONAL BUREAU OF FISH GENETIC RESOURCES   (India)

^c CEO   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ; HN PROTEIN; MEMBRANE PROTEIN; SIALIDASE;

ARTICLE; AVIAN INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DETECTION;

AMINO ACID SEQUENCE; ANIMALS; BIRDS; COMPUTATIONAL BIOLOGY; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEURAMINIDASE;

ANIMALIA; AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 40349084166     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2007.0037     Document Type: Article

References (31)

1. BHASIN, M., SINGH, H., and RAGHAVA, G.P.S. (2003). MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics, 19, 666-667.
2. + cytotoxic T cells: implications for vaccine design. Proc Natl Acad Sci USA 92, 5845-5849.
3. BITTLE, J.L., HOUGHTEN, R.A., ALEXEXANDER, H., SHINNICK, T.M., SUTCLIFFE, J.G., LERNER, R.A., et al. (1982). Protection against food and mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequences. Nature 298, 30-33.
4. CHEN, H., SMITH, G.J., ZHANG, S.Y., QIN, K., WANG, J., LIK, S., et al. (2005). Avian flu: H5N1 virus outbreak in migratory water fowl. Nature 436, 191-192.
5. COCHLOVIUS, B., STASSER, M., CHRIST, O., RADDRIZZANI, L., HAMMER, J., MYTILINEOS, I., et al. (2000). In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program. J Immunol 165, 4731-4741.
6. DE GROOT, A.S., and RAPPUOLI, R. (2004). Genome-derived vaccines. Expert Rev Vaccines 3, 59-76.
7. DE JONG, M.D., and HIEN, T.T. (2006). Avian influenza A (H5N1). J Clin Virol 35, 2-13.
8. DOOLAN, D.L., and HOFFMAN, S.L. (1997). Multigene vaccination against malaria: a multistage, multiimmune response approach. Parasitol Today 13, 171.
9. DA FONSECA, P.A.J., JOOSTEN, D., VAN DER ZEE, R., JUE, D., SINGH, M., VORDERMEIER, M., et al. (1998). Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides. Infect Immun 66, 3190-3197.
10. FOUCHIER, R.A., MUNSTER, V., WALLENSTEN, A., BESTEBROER, T.M., HERFST, S., SMITH, D., et al. (2005). Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black- headed gulls. J Virol 79, 2814-2822.
11. HAGMAN, M. (2000). Computer aided vaccine design. Science 290, 80-82.
12. HIEN, T.T., DEJONG, M., and FARRAR, J. (2004). Avian influenza - a challenge to global health care structures. N Engl J Med 351, 2363-2365.
13. HIORRIMOTON, T., and KAWAOKA, Y. (2005). Influenza: lessons from past pandemic warnings from current incidents. Nat Rev Microbiol 3, 591-600.
14. LEE, C.W., SUAREZ, D.L., TUMPEY, T.M., SUNG, H.W., KWONY, K., LEE, Y.J., et al. (2005). Characterization of highly pathogenic H5N1 avian influenza A viruses Isolated from South Korea. J Virol 79, 3692-3702.
15. LI, K.S., GUAN, Y., WANG, J., SMITH, G.J., XU, K.M., DUAN, L., et al. (2004) Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209-213.
16. LUND, O., NIELSEN, M., KESMIR, C., CHRISTENSEN, J.K., LUNDEGAARD, C., WORNING, P., et al. (2002). Web-based tools for vaccine design. In HIV Molecular Immunlogy (Los Alamos, NM, LA-UR 03-5816: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, pp. 45-51.
17. + cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med 189, 871-876.
18. MATROSOVICH, M.N., KRAUSS, S., and WEBSTER, R.G. (2001). H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 281, 156-162.
19. OBENAUER, J.C., DENSON, J., MEHTA, P.K., SA, X., MUKATORA, S., FINKELSTEIN, D.B., et al. (2006). Large scale sequences analysis of avian influenza isolates. Science 311, 1576-1580.
20. PIMTANOTHAI, N., PARRA, M., JOHNSON, A.H., DAVID, C.S., and KATOVICH, H.C. (2000). Assessing the binding of four Plasmodium falciparum T helper cell epitopes to HLA-DQ and induction of T-cell responses in HLADQ transgenic mice. Infect Immun 68, 1366.
21. RAPPUOLI, R. (2001). Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19, 2688-2691.
22. SCHWARTZ, B., and GELLIN, B. (2005). Vaccination strategies for an influenza pandemic. J Infect Dis 191, 1207-209.
23. SINGH, H., and RAGHAVA, G.P. (2003). ProPred1: prediction of promiscuous MHC class-I binding sites. Bioinformatics 19, 1009-1014.
24. SINGH, S.P., KHAN, F., and MISHRA, B.N. (2006). Genomic predictions for T Lymphocyte epitopes on Plasmodium falciparum (Malaria). Online J Bioinformatics 7, 69-73,
25. STEPHENSON, I., NICHOLSON, K.G., WOOD, J.M., ZAMBON, M.C., and KATZ, J.M. (2004). Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis 4, 499-509.
26. STOHR, K. (2003). The global agenda on influenza surveillance and control. Vaccine 21, 1744-1748.
27. TOES, R.E., NUSSBAUM, A.K., DEGERMANN, S., SCHIRLE, M., EMMERICH, N.P.N., KRAFT, M., et al. (2001). Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 194, 1-12.
28. TRAN, T.H., NGUYEN, T.L., NGUYEN, T.D., LUONG, T.S., PHAM, P.M., NGUYEN, V.C., et al. (2004). Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350, 1179-1188.
29. WANG, R., DOOLAN, D.L. Le, T.P., HEDSTROM, R.C., COONAN, K.M., CHAROENUIT, Y., et al. (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-448.
30. WEBBY, R.J., PEREZ, D.R., COLEMAN, J.S., GUAN, Y., KNIGHT, J.H., GOVORKOVA, E.A., et al. (2004). Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363, 1099-1103.
31. WHO. (2005). Cumulative number of confirmed human cases of avian influenza A/(H5N1)reported to WHO; (2005). http://www.who.int/csr/disease/ avianinfluenza/country/casestable20050608/en/index.html [accessed 10 August 2005].